CorMedix's DefenCath Ignites Stellar Q3 Performance, Elevating Full-Year Revenue Projections
Lyra Therapeutics Gambles on Higher Dose in New Phase 3 Trial Following Previous Setback for Chronic Rhinosinusitis Treatment
A New Horizon in Breast Cancer Treatment: AstraZeneca's Datroway Extends Lives and Boosts Hopes
Massachusetts' Biopharma Giant, Takeda, Announces Significant Layoffs Impacting 137 Employees in Cambridge Amidst Industry Restructuring
Telangana's Trillion-Dollar Leap: Eli Lilly Injects $1 Billion, Reshaping India's Pharma Future
Maharashtra Assures Safety: No Coldrif Syrup Found in State
India's Urgent Crusade: A Nationwide Crackdown on Contaminated Drugs After Tragic Child Deaths
Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings
Empowering Patients: Bristol-Myers Squibb Unveils Enhanced Digital Support for Opdivo
Pfizer's Pivotal Leap: BMO Analyst Seigerman Declares Bullish Outlook on Long-Awaited Obesity Market Entry via Metsara Deal
MBX Biosciences Rockets Skyward: Breakthrough Hypoparathyroidism Drug Unlocks Massive Pre-Market Surge!
The Epigenetics Revolution: Unlocking a $70 Billion Future by 2034
Ocugen Stock Rockets Upward: Unpacking the Latest Biotech Buzz
Aurobindo Pharma Under the Microscope: 8 USFDA Observations Rock Shares
Cell Therapy Manufacturing Market Set to Skyrocket to $18.89 Billion by 2034, Fueled by Chronic Disease Epidemic and Biotech Advancements
Sanofi's Eczema Breakthrough: A Scientific Triumph Meets a Skeptical Wall Street
MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs
Trump's Tariff Tangle: Will His 10% Plan Hike Your Drug Costs?
Trump's Bold Plan to Slash Drug Costs with Tariffs: A Risky Bet for American Consumers?
Cancer Breakthrough Ignites HCW Biologics: Stock Soars on Blockbuster Hopes
Unlocking Hope: The Global Race for a Cure in Focal Segmental Glomerulosclerosis